All Stories

  1. Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents

    Article • Current Molecular Medicine, August 2021, Bentham Science Publishers

    Professor Chris Orvig

  2. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates

    Article • Inorganic Chemistry, October 2019, American Chemical Society (ACS)

    Professor Chris Orvig

  3. Radiopharmaceuticals for diagnosis in nuclear medicine: a short review

    Article • Ecletica Quimica, July 2019, Ecletica Quimica Journal

    Professor Chris Orvig

  4. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models

    Article • European Journal of Medicinal Chemistry, July 2019, Elsevier

    Professor Chris Orvig

  5. Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry

    Article • Inorganic Chemistry, June 2019, American Chemical Society (ACS)

    Professor Chris Orvig

  6. In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands

    Article • European Journal of Medicinal Chemistry, November 2018, Elsevier

    Professor Chris Orvig

  7. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy

    Article • Chemical Reviews, October 2018, American Chemical Society (ACS)

    Professor Chris Orvig

  8. H4octox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry

    Article • Journal of the American Chemical Society, October 2018, American Chemical Society (ACS)

    Professor Chris Orvig

  9. H2hox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for 68Ga Radiopharmaceuticals

    Article • Inorganic Chemistry, July 2018, American Chemical Society (ACS)

    Professor Chris Orvig

  10. Multi-Target Metal-Based Anticancer Agents

    Article • Current Topics in Medicinal Chemistry, November 2017, Bentham Science Publishers

    Professor Chris Orvig

  11. Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes

    Article • Angewandte Chemie International Edition, November 2017, Wiley

    Professor Chris Orvig

  12. Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes

    Article • Angewandte Chemie International Edition, November 2017, Wiley

    Professor Chris Orvig

  13. Di- and Trivalent Metal-Ion Solution Studies with the Phosphinate-Containing Heterocycle DEDA-(PO)

    Article • Inorganic Chemistry, August 2017, American Chemical Society (ACS)

    Professor Chris Orvig

  14. A Perspective – can copper complexes be developed as a novel class of therapeutics?

    Article • Dalton Transactions, January 2017, Royal Society of Chemistry

    Professor Chris Orvig

  15. Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents

    Article • Dalton Transactions, January 2017, Royal Society of Chemistry

    Professor Chris Orvig

  16. H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions

    Article • Dalton Transactions, January 2017, Royal Society of Chemistry

    Professor Chris Orvig

  17. Dipicolinate Complexes of Gallium(III) and Lanthanum(III)

    Article • Inorganic Chemistry, November 2016, American Chemical Society (ACS)

    Professor Chris Orvig

  18. A comparative evaluation of the chelators H 4 octapa and CHX-A″-DTPA with the therapeutic radiometal 90 Y

    Article • Nuclear Medicine and Biology, September 2016, Elsevier

    Professor Chris Orvig

  19. Novel “bi-modal” H 2 dedpa derivatives for radio- and fluorescence imaging

    Article • Journal of Inorganic Biochemistry, September 2016, Elsevier

    Professor Chris Orvig

  20. Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p -xylenyl-linked quinolone ligands

    Article • Journal of Inorganic Biochemistry, September 2016, Elsevier

    Professor Chris Orvig

  21. In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, March 2016, Elsevier

    Professor Chris Orvig

  22. Evaluation of H2CHXdedpa, H2dedpa- and H2CHXdedpa-N,N′-propyl-2-NI ligands for 64Cu(ii) radiopharmaceuticals

    Article • Dalton Transactions, January 2016, Royal Society of Chemistry

    Professor Chris Orvig

  23. Gallium(iii) and iron(iii) complexes of quinolone antimicrobials

    Article • Dalton Transactions, January 2016, Royal Society of Chemistry

    Professor Chris Orvig

  24. Harnessing the bone-seeking ability of Ca(ii)-like metal ions in the treatment of metastatic cancer and resorption disorders

    Article • Chemical Society Reviews, January 2016, Royal Society of Chemistry

    Professor Chris Orvig

  25. Synthesis and characterization of lipophilic cationic Ga(iii) complexes based on the H2CHXdedpa and H2dedpa ligands and their 67/68Ga radiolabeling studies

    Article • RSC Advances, January 2016, Royal Society of Chemistry

    Professor Chris Orvig

  26. H2CHXdedpa and H4CHXoctapa—Chiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals

    Article • Inorganic Chemistry, January 2015, American Chemical Society (ACS)

    Professor Chris Orvig

  27. Ion Exchange in Hydroxyapatite with Lanthanides

    Article • Inorganic Chemistry, January 2015, American Chemical Society (ACS)

    Professor Chris Orvig

  28. In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders

    Article • Chemical Science, January 2015, Royal Society of Chemistry

    Professor Chris Orvig

  29. High-denticity ligands based on picolinic acid for 111In radiochemistry

    Article • Canadian Journal of Chemistry, August 2014, Canadian Science Publishing

    Professor Chris Orvig

  30. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with89Zr,111In and177Lu

    Article • Dalton Transactions, January 2014, Royal Society of Chemistry

    Professor Chris Orvig

  31. 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents

    Article • Metallomics, January 2014, Oxford University Press (OUP)

    Professor Chris Orvig

  32. Structural Characteristics of Chloroquine-Bridged Ferrocenophane Analogues of Ferroquine May Obviate Malaria Drug-Resistance Mechanisms

    Article • Journal of Medicinal Chemistry, February 2013, American Chemical Society (ACS)

    Professor Chris Orvig

  33. Werner coordination chemistry and neurodegeneration

    Article • Chemical Society Reviews, January 2013, Royal Society of Chemistry

    Professor Chris Orvig

  34. In vitro studies of lanthanide complexes for the treatment of osteoporosis

    Article • Dalton Transactions, January 2013, Royal Society of Chemistry

    Professor Chris Orvig

  35. Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease

    Article • Molecular BioSystems, January 2013, Royal Society of Chemistry

    Professor Chris Orvig

  36. Synthesis and in vitro anticancer activity of ferrocenyl-aminoquinoline-carboxamide conjugates

    Article • Inorganica Chimica Acta, December 2012, Elsevier

    Professor Chris Orvig

  37. H2azapa: a Versatile Acyclic Multifunctional Chelator for 67Ga, 64Cu, 111In, and 177Lu

    Article • Inorganic Chemistry, October 2012, American Chemical Society (ACS)

    Professor Chris Orvig

  38. The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases

    Article • Coordination Chemistry Reviews, October 2012, Elsevier

    Professor Chris Orvig

  39. RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga

    Article • Nuclear Medicine and Biology, August 2012, Elsevier

    Professor Chris Orvig

  40. 1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine Conjugates as Potential Antimalarials

    Article • Organometallics, June 2012, American Chemical Society (ACS)

    Professor Chris Orvig

  41. Modular Synthesis of 1,2- and 1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine and Mefloquine Conjugates as Potential Antimalarial Agents

    Article • Organometallics, June 2012, American Chemical Society (ACS)

    Professor Chris Orvig

  42. Evaluation of the H2dedpa Scaffold and its cRGDyK Conjugates for Labeling with 64Cu

    Article • Inorganic Chemistry, May 2012, American Chemical Society (ACS)

    Professor Chris Orvig

  43. H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals

    Article • Journal of the American Chemical Society, May 2012, American Chemical Society (ACS)

    Professor Chris Orvig

  44. 1,2-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents

    Article • Dalton Transactions, January 2012, Royal Society of Chemistry

    Professor Chris Orvig

  45. New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake

    Article • Nuclear Medicine and Biology, November 2011, Elsevier

    Professor Chris Orvig

  46. One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co

    Article • Dalton Transactions, January 2011, Royal Society of Chemistry

    Professor Chris Orvig

  47. N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy

    Article • Chemical Science, January 2011, Royal Society of Chemistry

    Professor Chris Orvig

  48. Biosorbents for hexavalent chromium elimination from industrial and municipal effluents

    Article • Coordination Chemistry Reviews, December 2010, Elsevier

    Professor Chris Orvig, Professor (Full) of Chemistry Bidyut Saha

  49. Acyclic Chelate with Ideal Properties for68Ga PET Imaging Agent Elaboration

    Article • Journal of the American Chemical Society, November 2010, American Chemical Society (ACS)

    Professor Chris Orvig

  50. Cationic technetium and rhenium complexes with pendant carbohydrates

    Article • Applied Radiation and Isotopes, June 2010, Elsevier

    Professor Chris Orvig

  51. Dalton Transactions: Increasing Impact

    Article • Dalton Transactions, January 2010, Royal Society of Chemistry

    Professor Chris Orvig

  52. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease

    Article • Dalton Transactions, January 2010, Royal Society of Chemistry

    Professor Chris Orvig

  53. Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

    Article • Chemical Reviews, October 2009, American Chemical Society (ACS)

    Professor Chris Orvig

  54. Stan Kirschner—An appreciation

    Article • Coordination Chemistry Reviews, August 2009, Elsevier

    Professor Chris Orvig

  55. Design, Synthesis, and Imaging of Small Amphiphilic Rhenium and99mTechnetium Tricarbonyl Complexes

    Article • Bioconjugate Chemistry, May 2009, American Chemical Society (ACS)

    Professor Chris Orvig

  56. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin

    Article • Journal of Inorganic Biochemistry, April 2009, Elsevier

    Professor Chris Orvig

  57. Vanadium treatment of type 2 diabetes: A view to the future

    Article • Journal of Inorganic Biochemistry, April 2009, Elsevier

    Professor Chris Orvig

  58. Long-chain rhenium and technetium glucosamine conjugates

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  59. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc)

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  60. Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  61. Divalent later transition metal complexes of the traditional chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  62. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  63. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  64. 2008: a record year for Dalton Transactions!

    Article • Dalton Transactions, January 2009, Royal Society of Chemistry

    Professor Chris Orvig

  65. Molecular Architectures for Trimetallic d/f/d Complexes: Magnetic Studies of a LnCu2Core

    Article • Inorganic Chemistry, April 2008, American Chemical Society (ACS)

    Professor Chris Orvig

  66. Molecular Architectures for Trimetallic d/f/d Complexes: Structural and Magnetic Properties of a LnNi2Core

    Article • Inorganic Chemistry, April 2008, American Chemical Society (ACS)

    Professor Chris Orvig

  67. Theoretical Studies of the Tautomers of Pyridinethiones

    Article • The Journal of Physical Chemistry A, April 2008, American Chemical Society (ACS)

    Professor Chris Orvig

  68. Pyridine−tert-Nitrogen−Phenol Ligands: N,N,O-Type Tripodal Chelates for the [M(CO)3]+Core (M = Re, Tc)

    Article • Inorganic Chemistry, February 2008, American Chemical Society (ACS)

    Professor Chris Orvig

  69. Dalton Transactions: providing the best services

    Article • Dalton Transactions, January 2008, Royal Society of Chemistry

    Professor Chris Orvig

  70. 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging

    Article • Chemical Communications, January 2008, Royal Society of Chemistry

    Professor Chris Orvig

  71. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease

    Article • Dalton Transactions, January 2008, Royal Society of Chemistry

    Professor Chris Orvig

  72. 55Cobalt complexes with pendant carbohydrates as potential PET imaging agents

    Article • Applied Radiation and Isotopes, December 2007, Elsevier

    Professor Chris Orvig

  73. Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimer's Therapy

    Article • Journal of the American Chemical Society, June 2007, American Chemical Society (ACS)

    Professor Chris Orvig

  74. Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation

    Article • Angewandte Chemie International Edition, February 2007, Wiley

    Professor Chris Orvig

  75. Lanthanide containing compounds for therapeutic care in bone resorption disorders

    Article • Dalton Transactions, January 2007, Royal Society of Chemistry

    Professor Chris Orvig

  76. Vanadium in diabetes: 100 years from Phase 0 to Phase I

    Article • Journal of Inorganic Biochemistry, December 2006, Elsevier

    Professor Chris Orvig

  77. Synthesis, Structure, and Biological Activity of Ferrocenyl Carbohydrate Conjugates

    Article • Inorganic Chemistry, October 2006, American Chemical Society (ACS)

    Professor Chris Orvig

  78. Carbohydrate-Appended 3-Hydroxy-4-pyridinone Complexes of the [M(CO)3]+Core (M = Re,99mTc,186Re)

    Article • Bioconjugate Chemistry, September 2006, American Chemical Society (ACS)

    Professor Chris Orvig

  79. Glucosamine Conjugates of Tricarbonylcyclopentadienyl Rhenium(I) and Technetium(I) Cores

    Article • Inorganic Chemistry, August 2006, American Chemical Society (ACS)

    Professor Chris Orvig

  80. Lanthanide(iii) and group 13 metal ion complexes of tripodal amino phosphinate ligands

    Article • Dalton Transactions, January 2006, Royal Society of Chemistry

    Professor Chris Orvig

  81. Metal complexes of maltol and close analogues in medicinal inorganic chemistry

    Article • Chemical Society Reviews, January 2006, Royal Society of Chemistry

    Professor Chris Orvig

  82. Metal complexes in medicinal chemistry: new vistas and challenges in drug design

    Article • Dalton Transactions, January 2006, Royal Society of Chemistry

    Professor Chris Orvig

  83. Design of targeting ligands in medicinal inorganic chemistry

    Article • Chemical Society Reviews, January 2006, Royal Society of Chemistry

    Professor Chris Orvig

  84. Editorial: Lanthanide compounds for therapeutic and diagnostic applications

    Article • Chemical Society Reviews, January 2006, Royal Society of Chemistry

    Professor Chris Orvig

  85. Carbohydrate-Bearing 3-Hydroxy-4-pyridinonato Complexes of Gallium(III) and Indium(III)

    Article • Bioconjugate Chemistry, November 2005, American Chemical Society (ACS)

    Professor Chris Orvig

  86. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications

    Article • Journal of Inorganic Biochemistry, November 2005, Elsevier

    Professor Chris Orvig

  87. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid

    Article • Journal of Inorganic Biochemistry, June 2005, Elsevier

    Professor Chris Orvig

  88. Carbohydrate-Appended 2,2‘-Dipicolylamine Metal Complexes as Potential Imaging Agents

    Article • Inorganic Chemistry, April 2005, American Chemical Society (ACS)

    Professor Chris Orvig

  89. Coordination Chemistry and Insulin-Enhancing Behavior of Vanadium Complexes with Maltol C6H6O3Structural Isomers

    Article • Inorganic Chemistry, April 2005, American Chemical Society (ACS)

    Professor Chris Orvig

  90. Group 13 and Lanthanide Complexes with MixedO,SAnionic Ligands Derived from Maltol

    Article • Inorganic Chemistry, April 2005, American Chemical Society (ACS)

    Professor Chris Orvig

  91. New Insights into the Interactions of Serum Proteins with Bis(maltolato)oxovanadium(IV):  Transport and Biotransformation of Insulin-Enhancing Vanadium Pharmaceuticals

    Article • Journal of the American Chemical Society, April 2005, American Chemical Society (ACS)

    Professor Chris Orvig

  92. Vanadium Complexes with MixedO,SAnionic Ligands Derived from Maltol:  Synthesis, Characterization, and Biological Studies

    Article • Inorganic Chemistry, April 2005, American Chemical Society (ACS)

    Professor Chris Orvig

  93. A glucosamine–dipicolylamine conjugate of99mTc(i) and186Re(i) for use in imaging and therapy

    Article • Dalton Transactions, January 2005, Royal Society of Chemistry

    Professor Chris Orvig

  94. Coordination chemistry of P, O-bidentate phosphinophenolates with Ga3+ and In3+

    Article • Dalton Transactions, January 2005, Royal Society of Chemistry

    Professor Chris Orvig

  95. Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone

    Article • Journal of Inorganic Biochemistry, December 2004, Elsevier

    Professor Chris Orvig

  96. Novel Carbohydrate-Appended Metal Complexes for Potential Use in Molecular Imaging

    Article • Chemistry - A European Journal, November 2004, Wiley

    Professor Chris Orvig

  97. Carbohydrate Conjugates for Molecular Imaging and Radiotherapy: 99mTc(I) and186Re(I) Tricarbonyl Complexes ofN-(2‘-Hydroxybenzyl)-2-amino-2-deoxy-d-glucose

    Article • Bioconjugate Chemistry, July 2004, American Chemical Society (ACS)

    Professor Chris Orvig

  98. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes

    Article • Journal of Inorganic Biochemistry, May 2004, Elsevier

    Professor Chris Orvig

  99. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid

    Article • Journal of Inorganic Biochemistry, January 2004, Elsevier

    Professor Chris Orvig

  100. Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats

    Article • Canadian Journal of Physiology and Pharmacology, November 2003, Canadian Science Publishing

    Professor Chris Orvig

  101. Boon and Bane of Metal Ions in Medicine

    Article • Science, May 2003, American Association for the Advancement of Science

    Professor Chris Orvig

  102. dlfComplexes with Uniform Coordination Geometry:  Structural and Magnetic Properties of an LnNi2 Core Supported by a Heptadentate Amine Phenol Ligand

    Article • Inorganic Chemistry, March 2003, American Chemical Society (ACS)

    Professor Chris Orvig

  103. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential

    Article • JBIC Journal of Biological Inorganic Chemistry, January 2003, Springer Science + Business Media

    Professor Chris Orvig

  104. Vanadyl−Thiazolidinedione Combination Agents for Diabetes Therapy

    Article • Bioconjugate Chemistry, January 2003, American Chemical Society (ACS)

    Professor Chris Orvig

  105. Synthesis and solution studies of the complexes of pyrone analogue ligands with vanadium(IV) and vanadium(V)

    Article • Inorganica Chimica Acta, November 2002, Elsevier

    Professor Chris Orvig

  106. Reduction of [VO2(ma)2]-and [VO2(ema)2]-by Ascorbic Acid and Glutathione:  Kinetic Studies of Pro-Drugs for the Enhancement of Insulin Action†

    Article • Inorganic Chemistry, March 2002, American Chemical Society (ACS)

    Professor Chris Orvig

  107. Two-Dimensional (2D) Pulsed Electron Paramagnetic Resonance Study of VO2+−Triphosphate Interactions:  Evidence for Tridentate Triphosphate Coordination, and Relevance To Bone Uptake and Insulin Enhancement by Vanadium Pharmaceuticals

    Article • Journal of the American Chemical Society, March 2002, American Chemical Society (ACS)

    Professor Chris Orvig

  108. Synthesis and Solution Studies of the Complexes of Trivalent Lanthanides with the Tetraazamacrocycle TETA-(PO)2

    Article • Inorganic Chemistry, January 2002, American Chemical Society (ACS)

    Professor Chris Orvig

  109. Article • Molecular and Cellular Biochemistry, January 2002, Springer Science + Business Media

    Professor Chris Orvig

  110. Influence of Chelation and Oxidation State on Vanadium Bioavailability, and Their Effects on Tissue Concentrations of Zinc, Copper, and Iron

    Article • Biological Trace Element Research, January 2002, Springer Science + Business Media

    Professor Chris Orvig

  111. Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes

    Article • Bioorganic & Medicinal Chemistry Letters, December 2001, Elsevier

    Professor Chris Orvig

  112. Coordination chemistry of vanadium in metallopharmaceutical candidate compounds

    Article • Coordination Chemistry Reviews, October 2001, Elsevier

    Professor Chris Orvig

  113. Insulin-Enhancing Vanadium(III) Complexes

    Article • Inorganic Chemistry, August 2001, American Chemical Society (ACS)

    Professor Chris Orvig

  114. [ReO(N2O2)X] Complexes:  “4 + 1”?

    Article • Inorganic Chemistry, August 2001, American Chemical Society (ACS)

    Professor Chris Orvig

  115. Lanthanide Chemistry with Bis{[bis(carboxymethyl)amino]methyl}phosphinate:  What Does an Extra Phosphinate Group Do to EDTA?

    Article • Inorganic Chemistry, July 2001, American Chemical Society (ACS)

    Professor Chris Orvig

  116. Sugar-Pendant Diamines

    Article • The Journal of Organic Chemistry, April 2001, American Chemical Society (ACS)

    Professor Chris Orvig

  117. Chemistry of Re withN,N‘-Bis(2-pyridylmethyl)ethylenediamine (H2pmen):  Hydrolysis, Dehydrogenation, and Ternary Complexes

    Article • Inorganic Chemistry, April 2001, American Chemical Society (ACS)

    Professor Chris Orvig

  118. Effects of Sequential Replacement of −NH2by −OH in the Tripodal Tetraamine Tren on Its Acidity and Metal Ion Coordinating Properties†

    Article • Inorganic Chemistry, March 2001, American Chemical Society (ACS)

    Professor Chris Orvig

  119. Proton- and lanthanide-coordinating properties of the tetraaza macrocycle (EDDA-KA)2 in aqueous solution

    Article • Canadian Journal of Chemistry, January 2001, Canadian Science Publishing

    Professor Chris Orvig

  120. Seven-Coordinate [ReVON4X2]+Complexes (X = O and Cl)†

    Article • Inorganic Chemistry, December 2000, American Chemical Society (ACS)

    Professor Chris Orvig

  121. Coaggregation of Paramagnetic d- and f-Block Metal Ions with a Podand-Framework Amine Phenol Ligand†

    Article • Inorganic Chemistry, February 2000, American Chemical Society (ACS)

    Professor Chris Orvig

  122. Homotrinuclear Lanthanide(III) Arrays:  Assembly of and Conversion from Mononuclear and Dinuclear Units†

    Article • Inorganic Chemistry, February 2000, American Chemical Society (ACS)

    Professor Chris Orvig

  123. Acid–base and metal ion-binding properties of diaminopropyl D-glucopyranoside and diaminopropyl D-mannopyranoside compounds in aqueous solution

    Article • Journal of the Chemical Society Dalton Transactions, January 2000, Royal Society of Chemistry

    Professor Parisa Mehrkhodavandi, Professor Chris Orvig

  124. Design of vanadium compounds as insulin enhancing agents

    Article • Journal of the Chemical Society Dalton Transactions, January 2000, Royal Society of Chemistry

    Professor Chris Orvig

  125. In Vivo Electron Spin−Echo Envelope Modulation (ESEEM) Spectroscopy:  First Observation of Vanadyl Coordination to Phosphate in Bone

    Article • Journal of the American Chemical Society, December 1999, American Chemical Society (ACS)

    Professor Chris Orvig

  126. Active Oxygen Species Formation in Synaptosomes Exposed to an Aluminum Chelator

    Article • Neurotoxicology and Teratology, May 1998, Elsevier

    Professor Chris Orvig

  127. Glucose-lowering properties of vanadium compounds: Comparison of coordination complexes with maltol or kojic acid as ligands

    Article • Journal of Inorganic Biochemistry, November 1997, Elsevier

    Professor Chris Orvig

  128. Selectivity among, and aggregation of, lanthanide ions

    Article • Journal of Alloys and Compounds, March 1997, Elsevier

    Professor Chris Orvig

  129. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats

    Article • Canadian Journal of Physiology and Pharmacology, January 1996, Canadian Science Publishing

    Professor Chris Orvig

  130. Highly Symmetric Group 13 Metal−Phosphinato Complexes:  Multinuclear NMR (27Al, 31P, 71Ga) Determination of Stability Constants at Low pH

    Article • Journal of the American Chemical Society, January 1996, American Chemical Society (ACS)

    Professor Chris Orvig

  131. Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent

    Article • Journal of the American Chemical Society, December 1995, American Chemical Society (ACS)

    Professor Chris Orvig

  132. Evidence for energy-dependent transport of aluminum out of brain extracellular fluid

    Article • Toxicology, April 1995, Elsevier

    Professor Chris Orvig, Professor Robert A Yokel

  133. Increased potency of vanadium using organic ligands

    Article • Molecular and Cellular Biochemistry, January 1995, Springer Science + Business Media

    Professor Chris Orvig

  134. Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy

    Article • Toxicology, September 1994, Elsevier

    Professor Chris Orvig, Professor Robert A Yokel

  135. Bis(maltolato)oxovanadium(IV) is a potent insulin mimic

    Article • Journal of Medicinal Chemistry, April 1992, American Chemical Society (ACS)

    Professor Chris Orvig

  136. Potential 67Ga radiopharmaceuticals for myocardial imaging: Tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes

    Article • International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology, April 1992, Elsevier

    Professor Chris Orvig

  137. General method for the synthesis of trishydroxamic acids

    Article • Tetrahedron Letters, March 1992, Elsevier

    Professor Chris Orvig

  138. Design and synthesis of multidentate 2-(2′-hydroxyphenyl)-2-thiazolines for biomedical application

    Article • Tetrahedron, January 1992, Elsevier

    Professor Chris Orvig

  139. Structural characterization of the octachloroditechnetate(III) ion in its tetrabutylammonium salt

    Article • Inorganic Chemistry, September 1981, American Chemical Society (ACS)

    Professor Chris Orvig